44 results
Page 2 of 3
8-K
EX-99.1
pvrd9
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
zv27inssitrlr6zet
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
r29 u95ti7
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
jmh5mpcmiznunckom6
9 Nov 21
Ligand Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
5ulhmhm
29 Jul 21
Ligand Reports Second Quarter 2021 Financial Results
4:04pm
8-K
EX-99.1
yjgidjf24yxrje
3 May 21
Ligand Reports First Quarter 2021 Financial Results
4:11pm
8-K
EX-99.1
xcbekxeml
3 Feb 21
Ligand Reports Fourth Quarter and Full Year 2020 Financial Results
7:45am
8-K
EX-99.1
c3ujv 4ri2k9d
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K
EX-99.1
y2xdiaph1xpyfzc32kem
30 Oct 20
Ligand Reports Third Quarter 2020 Financial Results
8:03am
8-K
EX-99.1
f78p1
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
xlu970tfqubq
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.1
cm9wsm8aa
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm